Apr 18 | Bio-IT World News Brief | A large coalition of European and American researchers this week published a new gene expression study of trisomy 21, better known as Down's syndrome, using a novel cellular model of the disorder.
Apr 17 | Bio-IT World | Genetic diagnostics is a growing field with great promise for improving medical care—yet interpreting the results of tests is a painstaking process, and different labs can disagree on which variants contribute to disease. As open science advocates seek to collect together and curate our knowledge of disease-related genes, the reluctance of many clinical labs to share their data continues to hinder progress.
Apr 15 | Forbes | Novartis bows out of RNAi research, the second big pharma to do so.
Apr 15 | Bio-IT World News Brief | The U.S. Patent and Trademark Office this morning issued the first patent to cover CRISPR-Cas9 gene editing, awarding the Broad Institute a patent for a version of the CRISPR-Cas9 system used to modify the DNA of mammalian cells.
Apr 14 | U-T San Diego | San Diego-based Edico Genome is working on a chip-based system, the Dragen Wavefront Processor, to perform first-line analysis of genetic information in a fraction of the time required by the fastest current methods.
Apr 11 | Bio-IT World News Brief | Bio-Rad has acquired GnuBIO, a next-generation droplet-based DNA sequencing technology. GnuBIO's DNA sequencing solution integrates the entire sample preparation workflow on a chip.
Apr 10 | Duke Chronicle | Duke's plans for the Institute for Genome Sciences & Policy were made public in late March--a formal dismantling July 1.
Apr 10 | Computerworld | A string of price cuts from Google, Amazon Web Services, and Microsoft has further driven down the price of cloud computing.
Apr 10 | Bio-IT World News Brief | Celladon today became the first company to receive breakthrough status for a gene therapy treatment in development. The treatment, MYDICAR, is intended to reduce the risk of heart failure in patients with a deficiency of the enzyme SERCA2a.
Apr 10 | Bio-IT World | A few months after Aspera's acquisition by IBM, Bio-IT World caught up with Aspera CEO Michelle Munson, a Bio-IT World Conference & Expo speaker and exhibitor, to hear the latest on life at Big Blue and what’s new in Aspera’s pipeline.
Apr 09 | Bio-IT World Roundup | More challenges for India's Open Source Drug Development project. The Indian Ministry of Science and Technology reportedly did not clear the cabinet note meant to extend funding for the Open Source Drug Discovery project and the project is facing a serious talent shortage.
Apr 08 | Bio-IT World Roundup | A March 26 Nature comment is getting press today. Steve Perrin, chief scientific officer at the ALS Therapy Development Institute in Cambridge, Mass., is frustrated with the mouse models driving ALS research.
Apr 07 | Technology Review | Data presented at the American Association of Cancer Researchers (AACR) event over the weekend heralded the revival of cancer immunotherapy.
Apr 07 | Computerworld | Computerworld released its 2014 Salary Survey for tech workers today. Compared with last year, salaries inched up slowly, but with more employees seeing increases.
Apr 04 | Huffington Post | A practicing bioinformatician makes the case for genomic research organizations to make their data public.
Apr 04 | Bio-IT World | The new LiveDesign platform, released this week, allows computational and medicinal chemists to cooperate in the cloud, drawing new compounds and running predictive models on them during live sessions.
Apr 03 | Bio-IT World News Brief | Appistry, which has managed the commercial releases of the Broad Institute's Genome Analysis Toolkit (GATK) since 2012, has released the GATK 3 for commercial use.
Apr 02 | Cornell Chronicle | Cornell University has established a new Center for Reproductive Genomics (CRG) with the help of a five-year, $10 million grant from NIH.
Apr 02 | Bio-IT World News Brief | This morning, 23andMe announced the appointment of industry veteran Kathy Hibbs as chief legal and regulatory officer, filling a role that has been vacant for nearly a year.
Apr 02 | Bio-IT World Roundup | A Japanese scientific committee yesterday found that the lead author of the acid-induced stem cell paper published in Nature is guilty of scientific misconduct.